ArticleCancer discovery2020

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.

Shanshan Pei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.